ARCHIVES

Genasense Added To Chemo Improves Responses in CLL

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | December 31, 2004

Download PDF Visit The Full Archive

Related Articles

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

Ratain To Lead New Center For Personalized Therapeutics At University of Chicago. Report Calls For Better Risk Stratification And New Name For DCIS.

January 22, 2010

$3.3 Million For Retinoid Contract Awarded

October 14, 1977

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

Study Finds Trial Results Reliable At Three Years

July 29, 2005